z-logo
open-access-imgOpen Access
15. Is Certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement?
Author(s) -
Aoife McVey,
Imna Rahiman,
Yeeho Chiu
Publication year - 2017
Publication title -
rheumatology advances in practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.539
H-Index - 4
ISSN - 2514-1775
DOI - 10.1093/rap/rkx006
Subject(s) - medicine , dermatology , psoriatic arthritis , certolizumab pegol , psoriasis , adalimumab , rheumatoid arthritis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom